
Arbozil-CT 40/12.5 Tablet
Marketer
Zuventus Healthcare Ltd
Salt Composition
Azilsartan medoxomil (40mg) + Chlorthalidone (12.5mg)
Overview Arbozil-CT 40/12.5 Tablet
Combining the active ingredients of Arbozil-CT 40/12.5 Tablet effectively manages hypertension by promoting vasodilation and optimizing cardiac output. This dual-action medication also facilitates diuresis, removing excess fluid and specific electrolytes. Convenience is enhanced by its ability to be administered with or without food; however, consistent timing is crucial for optimal therapeutic effect. Dosage and frequency should always adhere to your physician's prescribed regimen. Continuous use, as directed, is essential; premature discontinuation may exacerbate symptoms. Potential side effects include fatigue, hypokalemia, hypotension, elevated creatinine, and hyperuricemia. Increased fluid intake is recommended. Dizziness is possible; therefore, avoid activities requiring alertness until the medication's effects are assessed. Regular blood pressure monitoring is mandatory. Prior to commencing treatment, inform your doctor of pregnancy, breastfeeding, circulatory disorders, hepatic or renal impairment, and any other concurrent medications, as drug interactions can impact efficacy and action.
Primary Ingredients of Arbozil-CT 40/12.5 Tablet
No text provided. Please provide the text you would like me to rephrase.
Uses of Arbozil-CT 40/12.5 Tablet
Elevated blood pressure
Major Benefits of Arbozil-CT 40/12.5 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Arbozil-CT 40/12.5 Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Arbozil-CT 40/12.5 Tablet:
- Dizziness
- Tiredness
- Decreased potassium level in blood
- Decreased blood pressure
- Increased creatinine level in blood
- Increased uric acid level in blood
How to use Arbozil-CT 40/12.5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Arbozil-CT 40/12.5 Tablet whole; do not alter its form by chewing, crushing, or breaking. While it can be taken with or without food, consistency is key—maintain a regular administration schedule.
How Arbozil-CT 40/12.5 Tablet works:
Arbozil-CT 40/12.5 Tablets combine azilsartan medoxomil, an angiotensin receptor blocker (ARB), with chlorthalidone, a diuretic, to achieve effective blood pressure reduction. Azilsartan medoxomil's action involves inhibiting angiotensin, a hormone that constricts blood vessels. This inhibition promotes vasodilation, easing blood flow and reducing cardiac workload. Chlorthalidone facilitates diuresis, eliminating excess fluid and electrolytes, and also contributes to vasodilation and improved circulation over time.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Arbozil-CT 40/12.5 tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Use of Arbozil-CT 40/12.5 Tablet is contraindicated in pregnancy due to established fetal risks. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the hazards. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Arbozil-CT 40/12.5 tablets are considered safe for use while breastfeeding. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Taking Arbozil-CT 40/12.5 Tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should use Arbozil-CT 40/12.5 Tablet cautiously, potentially requiring dosage modification. Physician consultation is advised; this medication is generally not recommended for such individuals.
LiverCAUTION
Patients with liver impairment should use Arbozil-CT 40/12.5 tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Arbozil-CT 40/12.5 tablets are contraindicated in those with severe hepatic dysfunction.
What if you forget to take Arbozil-CT 40/12.5 Tablet :
Should you forget to take your Arbozil-CT 40/12.5 Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Arbozil-CT 40/12.5 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
